CytomX Therapeutics Inc’s filing revealed that its Chief Financial Officer Ogden Christopher unloaded Company’s shares for reported $28540.0 on Jun
CytomX Therapeutics Inc’s recently made public that its CEO McCarthy Sean A. unloaded Company’s shares for reported $22556.0 on Mar
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. CytomX Therapeutics